Title: Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk
1Surrogate Measures of Atherosclerosis and
Implications for Evaluating Cardiovascular Risk
- Nathan D. Wong, Ph.D., F.A.C.C.
- Associate Professor and Director
- Heart Disease Prevention Program
- University of California, Irvine
2Why use surrogate measures?
- CHD events often occur with no clinical history
and often normal risk factors (e.g., total
cholesterol is a poor predictor) - Most heart attacks result from coronary lesions
of less than 50 stenosis, often undetectable by
traditional methods (exercise test, angiogram) - Subclinical atherosclerosis (carotid IMT, ABI,
CAC?) predicts coronary events - Need to identify disease early enough to
intervene to prevent clinical events
3Features of Using Surrogate Measures of
Atherosclerosis
- Use as intermediate endpoints rather than waiting
until hard endpoints occur - May have implications for identifying and
tracking earlier, subclinical disease - Compared to clinical event studies, studies of
surrogate endpoints are lower cost, require fewer
subjects, less-follow-up - Use to follow progression of disease and effects
of medical intervention
4Use of Coronary Angiography in Early Studies of
Surrogate Endpoints
- The first trials of surrogate endpoints in the
late 1980s involved coronary angiography - Cholesterol Lowering Atherosclerosis Study (CLAS)
used a qualitative angiographic scoring in CABG
pts studied 2 years apart. - FATS and Lifestyle Heart Trial Quantitative
Coronary Angiography - Coronary angiography is expensive, may
underestimate disease, examines only selected
segments, limited to CAD patients
5Primary Modalities for Measuring Atherosclerotic
Burden
- Carotid B-mode ultrasonography intimal medial
thicknesses - CT (EBT or multislice detectors) coronary
calcium score or volume - Magnetic resonance imaging of carotid plaques
vessel wall area - Intravascular ultrasound (invasive)
- Brachial ultrasound
6Other Noninvasive Measures Associated with
Cardiovascular Risk
- Ankle-Brachial Index (ABI) for assessment of
peripheral vascular disease - Echocardiographic left ventricular mass /
hypertrophy, systolic (incl. Ejection fraction)
and diastolic function - Pulse wave velocity / arterial compliance for
assessing large artery stiffness
7Carotid B-Mode Ultrasonography
- Measurement of intimal medial thickness
- Non-invasive, inexpensive, no radiation
- Well-established as an indicator of
cardiovascular risk from epidemiologic studies - Published clinical trials on utility of carotid
IMT as measure of progression of atherosclerosis
and effects of therapy
8Carotid B-mode Ultrasonography Studies
- Atherosclerosis Risk in Communities (ARIC) (Black
and White subjects aged 45-64) RR 5.1 in women,
1.9 in men for IMT gt 1 mm vs. lt 1 mm (Chambless
et al, 1997). - Cardiovascular Health Study (CHS) (predominantly
White, aged 65) MI or stroke rate 25 over 7
years in those at highest quintile of combined
IMT (OLeary et al. 1999)
9Cardiovascular Health Study Combined
intimal-medial thickness predicts total MI and
stroke
10Carotid IMT Clinical Trials
- ACAPS showed lovastatin therapy in those aged
40-79 with elevated LDL-C to be associated with
regression in maximal IMT (Furberg et al., Circ
1994 90 1679-87) - KAPS showed in men 45-65 a 45 lower rate of
progression in those treated with pravastatin
(Salonen et al., Circ 1995 92 1758-64).
11Coronary Calcium Evaluation EBT and
Multidetector Scanners
- Non-invasive, moderate cost, convenient
- Detects location and quantity (score, mass,
volume) of coronary calcium, estimating burden
of atherosclerosis - Highly sensitive for angiographic disease,
specificity variable depending on standard - Reproducibility good (best at higher scores) but
similar in EBT vs. multidetector scanners - Artifact noise greater in EBT scanners
12Coronary Calcium Scanning
- Coronary Artery Scanning Protocol
- Patient Preparation None
- ECG Triggered to 60-70 of the R to R interval
- 3mm contiguous scans
- From carina to the apex
13Interscan Variability Inversely Related to Mean
Calcium Score
14Coronary Calcium Risk Factors and Prognosis
- Coronary calcium quantity and prevalence
increases with age relation to risk factors
widely reported, by varies by study - Persons with coronary calcium more likely to
begin healthful lifestyle behaviors - Amount of coronary calcium associated with
greater risk of events from several selected
cohort studies
15Risk of Total Cardiovascular Events by Calcium
Quartile (n881)(compared to those with no
calcium age and risk-factor adjusted)Wong ND et
al., Am J Cardiol 86 295-8
16Coronary Calcium Progression
Progression of Right coronary artery calcium
score over 5 years
1993 1995 1997
Calcium Score 56 Calcium Score 90 Calcium
Score 128 Volume Score 45 Volume Score 78
Volume Score 113
17Coronary Calcium Progression
- Studies of serial EBT scanning show annual
progression of 22-52 per year - Observational study of statin therapy in 149
patients showed calcium volume over 1 year - 52 progression in those not treated
- regression (-7) alcium volume among those
treated aggressively to LDL-C lt120 mg/dl, and - moderate progression (25) in those treated less
aggressively (LDL-C gt120 mg/dl) - (Calister et al., NEJM 1998 339 1972-8).
18Progression of Coronary Calcium (cont)
- Other observational studies also show
cholesterol-lowering or other therapy to relate
to a reduced rate of progression (up to 50 in
some cases). - Preliminary data relating progression to events
- 269 asymp pts observed for 2.5 years. 20 of 22
events occurred in those with progression of
calcium (Raggi, Radiology 1999 213 351) - 225 asymp pts scanned avg 3 years apart 23 had
events and showed increase in score of 35/yr,
compared to 22 in those without events (Shah,
Circulation 2000 102 II 604)
19Flow Diagram Showing Interaction Between EBCT
Results and Clinical Management (Taylor et al.,
Western J Med 1999 171 339-41)
Click for larger picture